155 related articles for article (PubMed ID: 19372135)
1. The Xpc gene markedly affects cell survival in mouse bone marrow.
Fischer JL; Kumar MA; Day TW; Hardy TM; Hamilton S; Besch-Williford C; Safa AR; Pollok KE; Smith ML
Mutagenesis; 2009 Jul; 24(4):309-16. PubMed ID: 19372135
[TBL] [Abstract][Full Text] [Related]
2. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.
Melis JP; Kuiper RV; Zwart E; Robinson J; Pennings JL; van Oostrom CT; Luijten M; van Steeg H
DNA Repair (Amst); 2013 Dec; 12(12):1081-6. PubMed ID: 24084170
[TBL] [Abstract][Full Text] [Related]
3. The role of XPC: implications in cancer and oxidative DNA damage.
Melis JP; Luijten M; Mullenders LH; van Steeg H
Mutat Res; 2011; 728(3):107-17. PubMed ID: 21763452
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
5. Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma.
Budden T; van der Westhuizen A; Bowden NA
BMC Cancer; 2018 Jan; 18(1):100. PubMed ID: 29373959
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair.
Sugasawa K; Ng JM; Masutani C; Iwai S; van der Spek PJ; Eker AP; Hanaoka F; Bootsma D; Hoeijmakers JH
Mol Cell; 1998 Aug; 2(2):223-32. PubMed ID: 9734359
[TBL] [Abstract][Full Text] [Related]
7. p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites of UV-irradiation-induced DNA damage, in vivo.
Fitch ME; Cross IV; Ford JM
Carcinogenesis; 2003 May; 24(5):843-50. PubMed ID: 12771027
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.
He J; Zhu Q; Wani G; Sharma N; Han C; Qian J; Pentz K; Wang QE; Wani AA
J Biol Chem; 2014 Sep; 289(39):27278-27289. PubMed ID: 25118285
[TBL] [Abstract][Full Text] [Related]
9. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene.
Adimoolam S; Ford JM
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12985-90. PubMed ID: 12242345
[TBL] [Abstract][Full Text] [Related]
10. XPC multifaceted roles beyond DNA damage repair: p53-dependent and p53-independent functions of XPC in cell fate decisions.
Zebian A; El-Dor M; Shaito A; Mazurier F; Rezvani HR; Zibara K
Mutat Res Rev Mutat Res; 2022; 789():108400. PubMed ID: 35690409
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
12. Characterization of defective nucleotide excision repair in XPC mutant mice.
Cheo DL; Ruven HJ; Meira LB; Hammer RE; Burns DK; Tappe NJ; van Zeeland AA; Mullenders LH; Friedberg EC
Mutat Res; 1997 Mar; 374(1):1-9. PubMed ID: 9067411
[TBL] [Abstract][Full Text] [Related]
13. Subcellular distribution of RAD23B controls XPC degradation and DNA damage repair in response to chemotherapy drugs.
You X; Guo W; Wang L; Hou Y; Zhang H; Pan Y; Han R; Huang M; Liao L; Chen Y
Cell Signal; 2017 Aug; 36():108-116. PubMed ID: 28473198
[TBL] [Abstract][Full Text] [Related]
14. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.
Khan SG; Yamanegi K; Zheng ZM; Boyle J; Imoto K; Oh KS; Baker CC; Gozukara E; Metin A; Kraemer KH
Hum Mutat; 2010 Feb; 31(2):167-75. PubMed ID: 19953607
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of xeroderma pigmentosum group C regulates ultraviolet-induced DNA damage repair.
Shah P; Zhao B; Qiang L; He YY
Nucleic Acids Res; 2018 Jun; 46(10):5050-5060. PubMed ID: 29660033
[TBL] [Abstract][Full Text] [Related]
16. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein.
Nishi R; Okuda Y; Watanabe E; Mori T; Iwai S; Masutani C; Sugasawa K; Hanaoka F
Mol Cell Biol; 2005 Jul; 25(13):5664-74. PubMed ID: 15964821
[TBL] [Abstract][Full Text] [Related]
17. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
18. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
19. DMBA-induced toxic and mutagenic responses vary dramatically between NER-deficient Xpa, Xpc and Csb mice.
Wijnhoven SW; Kool HJ; Mullenders LH; Slater R; van Zeeland AA; Vrieling H
Carcinogenesis; 2001 Jul; 22(7):1099-106. PubMed ID: 11408355
[TBL] [Abstract][Full Text] [Related]
20. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation.
Yasuda G; Nishi R; Watanabe E; Mori T; Iwai S; Orioli D; Stefanini M; Hanaoka F; Sugasawa K
Mol Cell Biol; 2007 Oct; 27(19):6606-14. PubMed ID: 17682058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
